Enlarge Figure 5-3: 2013 AHA/ACC/TOS Treatment Algorithm for Patients With Overweight and Obesity. Jensen MD, et al. Circulation. 2014;129 (25 suppl 2):S102-138.

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, provides an update on ...

GPs are set to play a key role in delivering care for people with mild and moderate ME/CFS under a new delivery plan.

Aldeyra will host a conference call at 8:00 a.m. ET today, March 28, 2024, to discuss the clinical development plan for resubmission of the new drug application for reproxalap in dry eye disease.

The UC Regents greenlit UCSF’s plan to co-develop a clinical- and life-sciences building with a proton-beam therapy center for cancer treatment in an emerging neighborhood on San Francisco’s ...